Module 3: Secondary Pharmacology in Drug Discovery

Recorded On: 04/09/2026

image
image


This presentation will explore the role of secondary pharmacology in drug discovery, focusing on the identification and evaluation of off-target effects—pharmacological interactions of a compound with unintended targets. The session will highlight how secondary pharmacology assessments are integrated across all phases of drug discovery, and, when relevant, during clinical development and in regulatory submissions. The presentation will cover a range of methodological approaches, including in silico, in vitro, ex vivo, and in vivo studies used to assess the risk of off-target pharmacologic activity. The approach to off-target profiling across therapeutic modalities will be covered. Real-world case studies involving experimental compounds will be shared to illustrate practical applications and decision-making based on secondary pharmacology data.

Jean-Pierre Valentin, PhD, HDR, ERT, DSP, FRCPath

Jean-Pierre Valentin, PhD, HDR, ERT, DSP, FRCPath

Senior Director

UCB

Dr. Jean-Pierre Valentin is a scientist with more than 30 years of experience in the pharmaceutical industry in a variety of scientific and leadership roles. After earning his PhD in Physiology and Pharmacology from the University of Montpellier, France, he completed a postdoctoral fellowship at UCSF. He began his career at the Pierre Fabre Research Centre, where he contributed to the discovery and progression of three candidate drugs. 

He then joined AstraZeneca, where he established and led the Department of Safety Pharmacology, contributing to the safety evaluation of approximately 200 candidate drugs across a wide range of therapeutic areas, several of which advanced to successful registration. In 2014, he moved to UCB-Biopharma as Senior Director to lead the Investigative Toxicology unit, supporting the company’s portfolio across multiple therapeutic areas and drug modalities, currently acting as Fellow, Strategic Advisor. 

Dr. Valentin is actively engaged in the scientific community. He is a former President of the Safety Pharmacology Society; current co-chair of the HESI Proarrhythmia Subcommittee and Cardiac Steering Team; and serves on the HESI Board of Trustees and Executive Committee. He also chairs the IQ-DruSafe Secondary Pharmacology Working Group and represents EFPIA on the ICH E14/S7B committee. 

He has been involved extensively in training, education, and mentoring through scientific societies, universities, and trade associations. He is the author or co-author of several patents and more than 250 peer-reviewed publications and book chapters.  

Key:

Complete
Failed
Available
Locked
Module 3 Secondary Pharmacology in Drug Discovery
Module 3: Secondary Pharmacology in Drug Discovery, Jean-Pierre Valentin, PhD, HDR, ERT, DSP, FRCPath
Recorded 04/09/2026  |  90 minutes
Recorded 04/09/2026  |  90 minutes As part of your registration, you will have unlimited access to the module recording for 30 days. Your 30-day access period begins when you first access the recording. Once the access period begins, it cannot be reset or restarted. To receive a certificate of completion, you must watch the recording for the minimum required viewing time. Please keep the recording open while viewing, as the system tracks your viewing time during the active session. If you close your browser before meeting the minimum viewing requirement, your viewing progress may not be retained. Once you have met the viewing requirement, the module survey will become available. After completing the survey, you will be able to access and download your certificate of completion. If you have any questions, please contact ACT Headquarters at [email protected].
Survey
13 Questions
13 Questions ACT values your feedback. Please help us continue to provide high-quality educational offerings by completing this short survey. The survey will become available after you have met the minimum viewing requirement for the recording. Once you complete the survey, your certificate of completion will become available on your dashboard or for download.
Certificate
No credits available  |  Certificate available
No credits available  |  Certificate available Your certificate of completion will become available after you have met the minimum viewing requirement and completed the module survey.